Health
Biotechnology
Pharmaceutical

Vertex Pharmaceuticals

$176.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-0.12%) Today
$0.00 (0.00%) As of 4:27 PM EDT after-hours

Why Robinhood?

You can buy or sell VRTX and other stocks, options, ETFs, and crypto commission-free!

About VRTX

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. Read More The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Employees
2,500
Headquarters
Boston, Massachusetts
Founded
1989
Market Cap
45.21B
Price-Earnings Ratio
21.22
Dividend Yield
0.00
Average Volume
1.31M
High Today
$177.93
Low Today
$175.60
Open Price
$176.47
Volume
615.94K
52 Week High
$195.81
52 Week Low
$151.80

Collections

Health
Biotechnology
Pharmaceutical
Manufacturing
Cancer Prevention
Therapy
Technology
US

VRTX News

Seeking AlphaJun 21

FDA approves expanded indication of Symdeko for cystic fibrosis

622
Yahoo FinanceJun 20

Vertex Pharmaceuticals Inc CEO & President Jeffrey M Leiden Sold $9.8 million of Shares

441
Seeking AlphaJun 17

Vertex Makes Strong Push Into Crispr Tech With 2 Deals At Once

214

VRTX Earnings

$0.53
$0.79
$1.04
$1.30
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 24, After Hours

More VRTX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.